Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

Circulation

Volumn 104, Issue 10, 2001, Pages 1108-1113

  Sharrett, A Richey ^a   Ballantyne, C M ^b   Coady, S A ^a   Heiss, G ^e   Sorlie, P D ^a   Catellier, D ^c   Patsch, W ^d  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d Salzburger Landeskliniken   (Austria)

^e MSC 7934 ^*

Author keywords

Apolipoproteins; Coronary disease; Follow up studies; Lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR RISK; DIABETES MELLITUS; FEMALE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SMOKING;

EID: 0035806916     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3501.095214     Document Type: Article

References (28)

1. National cholesterol education program: Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
2. Insights on treating an over-the-counter-type subgroup: Data from the Air Force/Texas Coronary Atherosclerosis Prevention Study population
3. A tale of two trials: The West of Scotland Coronary Prevention Study and the Texas Coronary Atherosclerosis Prevention Study
4. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: Methods and initial two years' experience
5. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease: The ARIC Study
6. 2+ precipitation procedure for quantification of high-density-lipoprotein cholesterol
7. Radioimmunoassay of apolipoprotein A-I: Application of a non-ionic detergent (Tween-20) and solid-phase staphylococcus
8. Zonal ultracentrifugation
9. Effect of blood collection and processing on radioimmunoassay results for apolipoprotein B in plasma
10. Human plasma lipoprotein[a]: Structural properties
11. Short-term intraindividual variability in lipoprotein measurements: The ARIC Study
12. Bootstrap confidence intervals: When, which, what?. A practical guide for medical statisticians
13. Association of coronary atherosclerosis with hyperapobetalipoproteinemia
14. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction
15. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT
16. Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS), I: Risk factors for myocardial infarction in a cohort of 5790 men
17. Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men
18. Hypertriglyceridemia as a cardiovascular risk factor
19. Lipoprotein(a) and coronary heart disease: Meta-analysis of prospective studies
20. Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study
21. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population
22. Lipoprotein(a) as a risk factor for preclinical atherosclerotic disease in a biracial cohort: The Atherosclerosis Risk in Communities (ARIC) Study
23. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease
24. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec Cardiovascular Study
25. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
26. Etiologic heterogeneity of hyperapobetalipoproteinemia (hyperapoB): Results from segregation analysis in families with premature coronary artery disease
27. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
28. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women